Finding the Path in Eosinophilic Esophagitis

Non-CME Corporate Forum

The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies or position of the American College of Allergy, Asthma & Immunology.

This activity is supported by an independent grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Target Audience

This program is intended for allergists/clinical immunologists, gastroenterologists, and other clinicians involved in the identification and management of patients with eosinophilic esophagitis (EoE).

Program Description

During this Call-a-Colleague™ program, specialists in allergy/immunology and eosinophilic gastrointestinal disease will discuss the disease burden, pathophysiology, diagnosis, and current management of eosinophilic esophagitis (EoE). Faculty will also present clinical trial evidence for emerging treatment options as well as considerations for patients with other atopic conditions. A unique feature of the program will be the “Call-a-Colleague” section where our specialists will elicit additional insight from their multidisciplinary team members, such as a dietitian, a psychologist, and a pediatric gastroenterologist. The clinicians will provide their expertise regarding the mental health burden among patients, the use of an elimination diet to resolve symptoms, and clinical issues pertaining to pediatric patients with EoE.

Learning Objectives

After completing this activity, participants will be better prepared to:

1. Describe the pathophysiologic mechanisms underlying EoE development, with a focus on potential therapeutic targets
2. Comprehensively assess pediatric and adult patients with suspected EoE to accelerate differential diagnoses and establish appropriate multidisciplinary care
3. Compare the clinical profiles, available trial evidence, and drawbacks of current and emerging treatment strategies for EoE
4. Longitudinally manage pediatric and adult patients with EoE based on symptoms, comorbidities, updated clinical guidelines, and therapeutic responses
5. Communicate with patients, caregivers, and members of the multidisciplinary team to ensure continuity of care and promote shared clinical decision-making

Program Agenda

8:30–8:40 PM Welcome & Preactivity Questions
8:40–8:55 PM An Overview of EoE: Burden & Pathophysiology
         Call a Colleague: Patient testimonial
8:55–9:20 PM Diagnosis and Evaluation of Patients With EoE
         Call a Colleague: Pathology Expert; Margaret Collins, MD
9:20–9:45 PM Long-term Multidisciplinary Management and Patient Communication
         Call a Colleague: Dietitian; Bethany Doerfler, MS, RD, LDN
9:45–10:00 PM Postactivity Questions and Q&A Session

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information & Refund/Cancellation Policy

There is no fee for this activity.

Integritas Communications Contact Information

For questions about this activity, please contact Integritas Communications at info@exchangecme.com.